Marieke Schurer

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

BresMed

Marieke Schurer is an author at Alnylam Pharmaceuticals (United States) specializing in health outcomes analysis, outcome valuation, and pharmacoeconomic review.

Publications per year

2021–2024

Publications

Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands

Marieke Schurer, Suzette M. Matthijsse, Carla Y. Vossen et al. · Value in Health · 2021 · 40 citations

Pharmacy, Health Policy, Pharmacoeconomics +17

Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study

Liz Gill, Sue Burrell, John Chamberlayne et al. · Orphanet Journal of Rare Diseases · 2021 · 14 citations · Full text

Medicine, Internal Medicine, Hepatology +9

The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement

Chafic Karam, Colleen Moffitt, Catherine Summers et al. · Orphanet Journal of Rare Diseases · 2024 · 11 citations · Full text

Medicine, Internal Medicine, Neurology +13

1–3 of 3